scispace - formally typeset
S

Sandrine Horman

Researcher at Université catholique de Louvain

Publications -  119
Citations -  5182

Sandrine Horman is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: AMPK & AMP-activated protein kinase. The author has an hindex of 35, co-authored 90 publications receiving 4487 citations. Previous affiliations of Sandrine Horman include Université libre de Bruxelles & Catholic University of Leuven.

Papers
More filters
Journal ArticleDOI

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

TL;DR: Findings reinforce the idea that pharmacological activation of AMPK may provide, through signalling and metabolic and gene expression effects, a new strategy for the management of metabolic hepatic disorders linked to type 2 diabetes and obesity.
Journal ArticleDOI

Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis

TL;DR: The activation of e EF2 kinase by AMPK, resulting in the phosphorylation and inactivation of eEF2, provides a novel mechanism for the inhibition of protein synthesis.
Journal ArticleDOI

AMPK inhibition in health and disease.

TL;DR: This review discusses recent findings that support the role and function of AMPK inhibition under physiological and pathological states and discusses the importance of whole body energy homeostasis.
Journal ArticleDOI

Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase α-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491

TL;DR: It is proposed that the effect of insulin to antagonize AMP-activatedprotein kinase activation involves a hierarchical mechanism whereby Ser485/Ser491 phosphorylation by protein kinase B reduces subsequent phosphorylated of Thr172 by LKB1 and the resulting activation of AMp-activated protein Kinase.
Journal ArticleDOI

AMPK: Lessons from transgenic and knockout animals.

TL;DR: Recent findings obtained from animal models with inhibition or activation of AMPK signaling pathway are discussed, including developments in transgenic and knockout mouse models.